USP General Chapter 800 governs the handling of hazardous drugs in healthcare settings. It is frequently discussed alongside USP 797, and the two are routinely confused, but they exist for opposite reasons: 797 protects the preparation from the people; 800 protects the people from the preparation. That single inversion drives every engineering difference between them.
It applies to all personnel who handle hazardous drug preparations and to all entities that store, transport, compound or administer them – pharmacies, hospitals, clinics, veterinary practices and physician offices. Unlike 797, it is not limited to sterile preparations: a hazardous tablet that must be crushed falls under it.
What makes a drug hazardous, and who decides
USP 800 does not maintain its own list. It defers to the NIOSH List of Hazardous Drugs in Healthcare Settings, which is the entity that determines scope. A drug is listed on criteria including carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, and structural or toxicity similarity to a drug already listed.
The practical consequence for a facility is that scope is not fixed at design time. NIOSH revises the list, and a facility that was out of scope can come into it without changing anything it does. Designing containment that can be extended is cheaper than designing to the current list exactly.
The chapter does allow proportionality through an Assessment of Risk. For certain dosage forms – final dosage forms that require no manipulation, for instance – an entity may document an assessment and adopt alternative containment strategies rather than full containment. That assessment is a formal, written, reviewed document, not an informal judgement, and it must be revisited when the list or the practice changes.
The containment engineering controls
| Term | What it is | Requirement | Design consequence |
|---|---|---|---|
| C-PEC – containment primary engineering control | The cabinet or isolator the handling occurs in: Class II biological safety cabinet or a containment aseptic containment isolator | Externally vented | Ducted exhaust to outside is mandatory – this is not a recirculating cabinet and cannot be sited on convenience |
| C-SEC – containment secondary engineering control | The room housing the C-PEC | Negative pressure 0.01 to 0.03 in w.c., at least 12 ACH, externally vented | The negative pressure band is narrow at both ends – too little is non-compliant, too much causes door and airflow problems |
| Sterile HD compounding | C-PEC inside a classified C-SEC | C-SEC classified ISO 7 with an ISO 7 ante-room, and 30 ACH where USP 797 applies | This is where 797 and 800 must both be satisfied at once |
| C-SCA – containment segregated compounding area | An unclassified room containing a C-PEC | Negative pressure, at least 12 ACH, externally vented | Permitted, but restricts the preparation to the shortest beyond-use dating under USP 797 |
| HD storage | Where hazardous drugs are stored | Negative pressure, at least 12 ACH, externally vented | Storage is frequently forgotten in design and is a common inspection finding |
External venting is the requirement that most often forces a building decision. A recirculating cabinet does not satisfy 800 for the drugs that require containment, and ducting to atmosphere constrains where the room can sit, how the roof or facade is penetrated, how the exhaust is monitored, and what happens to the pressure cascade when the fan fails. Retrofitting a vent path into an occupied building is routinely the largest single line item in an 800 remediation.
The USP 797 and USP 800 conflict, and how it is actually resolved
This is the part worth reading twice, because it is where designs fail. For a sterile hazardous preparation both chapters apply simultaneously, and their pressure requirements are opposed:
| USP 797 wants | USP 800 wants | |
|---|---|---|
| Objective | Protect the preparation from contamination | Protect personnel from the drug |
| Room pressure | Positive relative to less clean spaces | Negative relative to adjacent spaces |
| Air handling | HEPA-filtered supply, 30 ACH in classified rooms | At least 12 ACH, externally vented, no recirculation |
| Air movement | Inward to the clean space | Inward to the contaminated space |
Neither yields to the other. The resolution is architectural rather than a compromise on either requirement: the sterility objective is met by the C-PEC, and the containment objective is met by the room. The ISO 5 environment the preparation needs exists inside the cabinet or isolator; the room around it runs negative and externally vented for the operator. The ante-room then provides the pressure step that lets a negative buffer room sit inside an otherwise positive suite.
Two failure modes follow from getting the cascade wrong. Run the containment room positive to satisfy 797 and hazardous aerosol migrates toward staff. Run the whole suite negative to satisfy 800 and unclassified corridor air is drawn across the sterile work. The pressure cascade has to be resolved across every door in the suite, including the failure cases – fan failure, door held open, filter loaded – before construction, because it cannot be tuned into compliance afterwards.
Cleaning is four steps here, not one
Ordinary cleanroom practice does not satisfy 800, because a hazardous residue is a chemical hazard rather than a microbial one. The chapter requires a sequence, and each step does something the others cannot:
| Step | What it does | Why it cannot be skipped |
|---|---|---|
| Deactivation | Renders the hazardous drug residue inert | A disinfectant does not deactivate a cytotoxic residue – it may simply spread it |
| Decontamination | Removes the deactivated residue from the surface | Deactivated residue is still residue and still transfers |
| Cleaning | Removes remaining soil | Conventional cleaning, and only meaningful after the two steps above |
| Disinfection | Kills microorganisms | Only relevant where sterile compounding also occurs – this is the 797 step |
The material consequence is durability. Deactivating agents are aggressive, and surfaces get four treatments where a non-hazardous cleanroom gets one. Surface and material selection has to be made against the deactivating agent, not against the disinfectant, or finishes degrade within the life of the facility and become uncleanable – which converts a materials decision into a compliance failure.
What this means if you are building or remediating
- Establish scope against the current NIOSH list, and design for it to grow. The list is revised; containment that can be extended costs less than containment sized exactly to today.
- Decide sterile or non-sterile early. Non-sterile hazardous handling needs containment alone; sterile hazardous compounding needs containment plus the full 797 classified suite, and the two scopes are not comparable in cost.
- Resolve the exhaust route before anything else. External venting constrains room location, roof or facade penetration, fan redundancy and monitoring. It is the hardest thing to change later.
- Draw the pressure cascade across every door, including failure cases, and include the storage room – storage is negative and 12 ACH too, and is the most commonly missed space.
- Select surfaces against the deactivating agent. Then confirm the selection survives the full four-step regime, not just a disinfectant wipe.
- Design in continuous pressure monitoring with a record. A gauge nobody reads is not monitoring, and the record is what an inspector asks for.
Like USP 797, chapter 800 is compendial rather than a federal regulation in itself, and it takes practical force through state boards of pharmacy, accreditation bodies and – because it concerns worker exposure – occupational safety enforcement. Confirm the position in your own state.
Related guides and tools
- USP 797 explained – the sterile compounding side, CSP categories and the classified suite.
- Cleanroom air change and HEPA calculator – airflow, filter count and ceiling fit.
- Cleanroom classifications and ISO 14644.
- Cleanroom design and construction.
Get a single-source quote
Frequently asked questions
What is USP 800?
USP General Chapter 800 sets standards for handling hazardous drugs in healthcare settings, covering receipt, storage, compounding, transport, administration and disposal. Its purpose is to protect personnel, patients and the environment from exposure. It applies to all entities that handle hazardous drugs and to all personnel who do so, and it is not limited to sterile preparations.
What is the difference between USP 797 and USP 800?
They protect opposite things. USP 797 protects the preparation from contamination, which drives positive room pressure and HEPA-filtered air. USP 800 protects personnel from the drug, which drives negative pressure and mandatory external venting. Both apply at once to a sterile hazardous preparation, and neither overrides the other – the sterility objective is met by the containment cabinet and the containment objective by the room.
What pressure does USP 800 require?
Negative pressure between 0.01 and 0.03 inches water column relative to adjacent areas, in the containment secondary engineering control, in a containment segregated compounding area, and in hazardous drug storage. The band is narrow at both ends: too little is non-compliant and too much causes door operation and airflow problems.
How many air changes does USP 800 require?
At least 12 air changes per hour in containment areas and in hazardous drug storage. Where sterile hazardous compounding also brings USP 797 into scope, the classified room requirement of at least 30 air changes per hour applies as well – the higher figure governs, and the room must still be negative and externally vented.
Does USP 800 require external venting?
Yes. The containment primary engineering control must be externally vented, and containment rooms are externally vented with no recirculation. A recirculating cabinet does not satisfy the requirement. This is usually the hardest requirement to retrofit, because the exhaust route constrains room location, building penetration, fan redundancy and monitoring.
Which drugs does USP 800 apply to?
Those on the NIOSH List of Hazardous Drugs in Healthcare Settings. USP 800 does not maintain its own list – it defers to NIOSH, which lists drugs on criteria including carcinogenicity, teratogenicity, reproductive and organ toxicity at low doses, and genotoxicity. Because NIOSH revises the list, a facility can come into scope without changing anything it does.
What is an Assessment of Risk under USP 800?
A formal written assessment that lets an entity adopt alternative containment strategies for certain dosage forms rather than applying full containment – typically final dosage forms requiring no manipulation. It must be documented, reviewed and revisited when the NIOSH list or the practice changes. It is a governed document, not an informal judgement, and it is frequently examined at inspection.
What is the difference between a C-PEC and a C-SEC?
The containment primary engineering control is the cabinet or isolator the work happens in – a Class II biological safety cabinet or a containment aseptic containment isolator – and it must be externally vented. The containment secondary engineering control is the room housing it, which must be negative pressure, at least 12 air changes per hour and externally vented. The C-PEC contains the drug at the source; the C-SEC contains what escapes it.
Why does USP 800 cleaning have four steps?
Because a hazardous residue is a chemical hazard, not a microbial one. Deactivation renders the residue inert, decontamination removes it from the surface, cleaning removes remaining soil, and disinfection kills microorganisms where sterile compounding also applies. A disinfectant alone does not deactivate a cytotoxic residue and may simply spread it, which is why the order matters as much as the agents.
How does USP 800 affect surface and material selection?
Materially, and it is often overlooked. Surfaces receive four treatments rather than one, and deactivating agents are aggressive. Materials must be selected against the deactivating agent rather than against the disinfectant, or finishes degrade within the life of the facility and become uncleanable – turning a materials decision into a compliance failure that is expensive to remediate in an operating facility.
Is USP 800 enforceable?
It is a compendial chapter rather than a federal regulation in its own right, but it carries practical force through state boards of pharmacy that adopt it, through accreditation bodies, and – because it concerns worker exposure – through occupational safety enforcement. Adoption and timing vary by state, so confirm the position where you operate rather than assuming a single national effective date.
Can hazardous and non-hazardous compounding share a suite?
Yes, but the pressure cascade has to be designed for it rather than adapted afterwards. The non-hazardous buffer room runs positive under USP 797 while the containment room runs negative under USP 800, with the ante-room providing the pressure step between them. Adding containment to a suite designed only for positive pressure disturbs the cascade throughout and is usually more expensive than building both at the outset.